96826-41-4

Basic information

• Product Name: methyl 3-chloro-5-methoxybenzoate
• Synonyms: methyl 3-chloro-5-methoxybenzoate
• CAS NO: 96826-41-4
• Molecular Formula: C₉H₉ClO₃
• Molecular Weight: 200.61896
• Mol File: 96826-41-4.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 282.6±20.0 °C(Predicted)
• Appearance: /
• Density: 1.228±0.06 g/cm3(Predicted)
• CAS DataBase Reference: methyl 3-chloro-5-methoxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3-chloro-5-methoxybenzoate(96826-41-4)
• EPA Substance Registry System: methyl 3-chloro-5-methoxybenzoate(96826-41-4)

Safety Data

• Hazardous Substances Data: 96826-41-4(Hazardous Substances Data)

Upstream product

• 82477-67-6 3-chloro-5-methoxy-benzoic acid 
• 75-36-5 acetyl chloride 
• 51-36-5 3,5-dichlorobenzoic acid 
• 67-56-1 methanol 

Downstream Products

• 950525-41-4 1-(3-chloro-5-methoxyphenyl)-2-(pyridin-4-yl)ethanone 

Relevant articles and documents

Discovery of highly potent V600E-B-RAF kinase inhibitors: Molecular modeling study

A series of 20 triarylpyrazole derivatives containing amide or urea linker have been synthesized. Their in vitro antiproliferative activity against NCI-60 cancer cell lines panel has been reported. Upon investigating the mechanism of action at molecular l

Synthesis and inhibitory effects of triarylpyrazoles on LPS-induced NO and PGE2 productions in RAW 264.7 macrophages

Abstract: The inhibition of nitric oxide and prostaglandin E2 productions is a very interesting research topic in the field of anti-inflammatory drug development. In the current study, a new series of 1,3,4-triarylpyrazole derivatives was synth

Synthesis of 1H-Pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line

Synthesis of a new series of 1H-pyrazole-1-carboxamide derivatives is described. Their antiproliferative activity against A375 human melanoma cell line was tested and the effect of substituents on the diarylpyrazole scaffold was investigated. The pharmacological results indicated that most of the newly synthesized compounds showed moderate activity against A375, compared with sorafenib. Among all of these derivatives, compound IIe which has N-methylpiperazinyl and phenolic moieties showed the most potent antiproliferative activity against A375 human melanoma cell line.